MC225 compound: Clinical Trials

1 trial of MC225 compound, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow MC225 compound: new trials by email Literature Review of MC225 compound trials Research Report on MC225 compound

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
[18F]MC225-PET in Neurodegenerative Disease
[18F]MC225 - Neurodegenerative Diseases, Alzheimer Disease
Phase 1 / Phase 2UnknownUniversity Medical Center Groningen302022-02-012023-05-10

Conditions studied

Alzheimer Disease (1)  ·  Cognitive Dysfunction (1)  ·  Neurodegenerative Diseases (1)  ·  Parkinson Disease (1)

Sponsors

University Medical Center Groningen (1)

Countries

Netherlands (1)

Top investigators

Gert Luurtsema, Phd (1)